Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:HUM
CUSIP44485910
Phone502-580-1000
Debt
Debt-to-Equity Ratio0.47
Current Ratio1.55
Quick Ratio1.55
Price-To-Earnings
Trailing P/E Ratio25.78
Forward P/E Ratio22.55
P/E Growth1.64
Sales & Book Value
Annual Sales$53.77 billion
Price / Sales0.81
Cash Flow$15.2650 per share
Price / Cash20.68
Book Value$68.89 per share
Price / Book4.58
Profitability
EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins3.36%
Return on Equity16.74%
Return on Assets5.60%
Miscellaneous
Employees45,900
Outstanding Shares137,680,000
Market Cap$43,661.72
Humana (NYSE:HUM) Frequently Asked Questions
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana declared a quarterly dividend on Thursday, April 19th. Investors of record on Friday, June 29th will be paid a dividend of $0.50 per share on Friday, July 27th. This represents a $2.00 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date is Thursday, June 28th. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana declared that its Board of Directors has authorized a stock repurchase plan on Friday, December 15th 2017, which authorizes the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company's board believes its stock is undervalued.
How were Humana's earnings last quarter?
Humana Inc (NYSE:HUM) posted its quarterly earnings data on Wednesday, May, 2nd. The insurance provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.21 by $0.15. The insurance provider had revenue of $14.28 billion for the quarter, compared to analysts' expectations of $14.22 billion. Humana had a return on equity of 16.74% and a net margin of 3.36%. During the same period in the prior year, the firm posted $2.75 EPS. View Humana's Earnings History.
When is Humana's next earnings date?
What guidance has Humana issued on next quarter's earnings?
Humana updated its FY18 earnings guidance on Thursday, May, 31st. The company provided earnings per share guidance of $13.70-14.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $13.97.
What price target have analysts set for HUM?
16 brokers have issued 12-month price objectives for Humana's shares. Their predictions range from $221.00 to $362.00. On average, they expect Humana's share price to reach $293.00 in the next year. This suggests that the stock has a possible downside of 7.2%. View Analyst Ratings for Humana.
What is the consensus analysts' recommendation for Humana?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 5 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
What are Wall Street analysts saying about Humana stock?
Here are some recent quotes from research analysts about Humana stock:
- 1. According to Zacks Investment Research, "Shares of Humana have outperformed the industry year to date. The insurer is well-poised for growth on its strong government business. Its top line has been witnessing an uptrend for the past several years. Sufficient generation of cash flow has helped the company take up many capital deployment initiatives aimed at enhancing its shareholders’ value. Humana’s sound balance sheet and a disciplined capital management remain major tailwinds. Following better-than-expected first-quarter results, the company provided a strong guidance for 2018. Also, the company has exited the individual commercial business effective Jan 1, 2018. Rising level of expenses persistently weighs on the bottom line. With respect to quarterly results, Humana’s first-quarter bottom line beat estimates on a favorable current-year medical utilization in Retail segment relative, lower tax rate and a positive impact of share buybacks." (5/31/2018)
- 2. Cantor Fitzgerald analysts commented, "This morning, Humana announced it would acquire a 40% interest in Curo Health Services, a large, privately-held hospice company." (4/23/2018)
Who are some of Humana's key competitors?
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
- Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
- Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 55)
- Mr. Timothy S. Huval, Chief HR Officer (Age 52)
- Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
Has Humana been receiving favorable news coverage?
Media stories about HUM stock have trended positive this week, according to Accern. The research firm scores the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Humana earned a news sentiment score of 0.26 on Accern's scale. They also assigned media headlines about the insurance provider an impact score of 46.73 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
Who are Humana's major shareholders?
Humana's stock is owned by a number of of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.30%), Mckinley Capital Management LLC Delaware (0.07%), NN Investment Partners Holdings N.V. (0.06%), Gulf International Bank UK Ltd (0.03%), Scout Investments Inc. (0.03%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.
Which institutional investors are selling Humana stock?
HUM stock was sold by a variety of institutional investors in the last quarter, including Mckinley Capital Management LLC Delaware, Scout Investments Inc., Clinton Group Inc., Fjarde AP Fonden Fourth Swedish National Pension Fund, Empowered Funds LLC, Gateway Investment Advisers LLC, Gulf International Bank UK Ltd and CHURCHILL MANAGEMENT Corp. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.
Which institutional investors are buying Humana stock?
HUM stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, NN Investment Partners Holdings N.V., Pensionfund DSM Netherlands, Pensionfund Sabic, State of Alaska Department of Revenue, Atlas Brown Inc., First Citizens Bank & Trust Co. and IFM Investors Pty Ltd. View Insider Buying and Selling for Humana.
How do I buy shares of Humana?
Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of HUM stock can currently be purchased for approximately $315.68.
How big of a company is Humana?
Humana has a market capitalization of $43.66 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.
How can I contact Humana?
Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.
MarketBeat Community Rating for Humana (NYSE HUM)
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
